Bit Bio secures $41.5 M funding to produce human cells
Biospace - 15-Jun-2020UK-based startup reprogramming stem cells to generate new cell therapies
Join the club for FREE to access the whole archive and other member benefits.
Freelance writer at Biospace, BioBuzz
Alex Keown is a Chicago-based freelance writer and editor, currently working with BioBuzz and Biospace. Keown has more than 20 years of experience writing for publications in newspapers, online business news sites, journals and magazines. His work has been featured in The Chicago Tribune, BioSpace, BioBuzz, Patch.com, The Naperville Sun, My Suburban Life, The Wilson (Daily) Times, Fur World Magazine, Clef Notes Journal and more.
Visit website: http://www.alexkeown.com/
See alsoDetails last updated 12-Apr-2021
UK-based startup reprogramming stem cells to generate new cell therapies
Targeting brain function to address Parkinson’s and Alzheimer’s at their core
How MyndYou's speech-tracking technology is transforming diagnostics and care